Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Several Features Define a Hostile Neck in AAA patients, but Only One Makes the Difference

Patients with infrarenal abdominal aortic aneurysm (AAA) and ≥ 30 mm neck diameter have 3 times higher risk of type 1A endoleak and 5 times higher risk of rupture at follow up after standard endovascular aneurysm repair (EVAR), as well as lower survival rate. This could tilt the scales against EVAR, or at best call for closer follow up with CT in this subgroup of patients. These findings could also lead to the evolution of prosthesis technology.

El tratamiento endovascular parece superior a la cirugía en aneurismas rotosThis study looked at the outcomes of EVAR in patients with ≥ 30 mm neck diameter from the ENGAGE registry (Endurant Stent Graft Natural Selection Global Postmarket Registry). Patients with ≥ 30 mm neck diameter were retrospectively compared against patients with < 30 mm neck diameter. Primary end point was 1A endoleak rate, and secondary end point was reintervention, rupture and survival.

 

The registry included 1257 patients followed up at mean 4 years: 97 (7.7%) had ≥30 mm intrarenal neck diameter and were compared against the 1160 remaining patients (92.3%) with <30 mm diameter. There were no differences between the groups in terms of neck length, angulation, thrombus or calcification. Mean preoperative diameter was 64.6 ± 11.3 mm with ≥30 mm diameter vs 60 ± 11.6 mm in patients with <30-mm neck diameter, which resulted significant (p<0.01).


Read also: Risk of Colonic Ischemia after Abdominal Aortic Aneurysm Repair.


Five patients in the ≥30 mm diameter group (5.2%) and 30 in the <30 mm group (2.6%) developed type 1A endoleak at 4 years (p=0.9). However, after adjusting for length, aneurysm diameter and stent graft oversizing, researchers observed endoleak type 1A risk is far elevated in patients with ≥30 mm neck diameter (HR 3.0; IC 95%, 1.0-9.3; p=0.05).

 

Aneurysm rupture was also far more frequent in patients with large neck diameter (HR, 5.1; IC 95%, 1.4-19.2; p=0.016).

 

Survival at 4 years was 61.6% in patients with ≥30 mm neck diameter and 75.2% in patients with smaller neck diameter (p=0.009).

 

Conclusion

In this study, patients with infrarenal abdominal aortic aneurysm undergoing endovascular repair presenting ≥30 mm neck diameter, have a threefold increased risk of type 1A, endoleak and fivefold increased risk of rupture, and worse survival. These data must be confirmed but still could change the standard of care for this subgroup of patients or demand much closer follow up.

 

Original title: Patients with large neck diameter have a higher risk of type IA endoleaks and aneurysm rupture after standard endovascular aneurysm repair.

Reference: Nelson F. G. Oliveira et al. J Vasc Surg 2018, article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...